Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Cell Mol Immunol ; 18(2): 398-414, 2021 02.
Article in English | MEDLINE | ID: mdl-33408345

ABSTRACT

Signaling via interleukin-2 receptor (IL-2R) is a requisite for regulatory T (Treg) cell identity and function. However, it is not completely understood to what degree IL-2R signaling is required for Treg cell homeostasis, lineage stability and function in both resting and inflammatory conditions. Here, we characterized a spontaneous mutant mouse strain endowed with a hypomorphic Tyr129His variant of CD25, the α-chain of IL-2R, which resulted in diminished receptor expression and reduced IL-2R signaling. Under noninflammatory conditions, Cd25Y129H mice harbored substantially lower numbers of peripheral Treg cells with stable Foxp3 expression that prevented the development of spontaneous autoimmune disease. In contrast, Cd25Y129H Treg cells failed to efficiently induce immune suppression and lost lineage commitment in a T-cell transfer colitis model, indicating that unimpaired IL-2R signaling is critical for Treg cell function in inflammatory environments. Moreover, single-cell RNA sequencing of Treg cells revealed that impaired IL-2R signaling profoundly affected the balance of central and effector Treg cell subsets. Thus, partial loss of IL-2R signaling differentially interferes with the maintenance, heterogeneity, and suppressive function of the Treg cell pool.


Subject(s)
Colitis/immunology , Forkhead Transcription Factors/metabolism , Interleukin-2 Receptor alpha Subunit/metabolism , Mutation , T-Lymphocytes, Regulatory/immunology , Animals , Colitis/metabolism , Colitis/pathology , Female , Forkhead Transcription Factors/genetics , Homeostasis , Immunosuppression Therapy , Interleukin-2/metabolism , Interleukin-2 Receptor alpha Subunit/genetics , Male , Mice , Mice, Inbred C57BL , Signal Transduction
2.
Nat Commun ; 11(1): 1114, 2020 02 28.
Article in English | MEDLINE | ID: mdl-32111837

ABSTRACT

Little is known regarding lymph node (LN)-homing of immune cells via afferent lymphatics. Here, we show, using a photo-convertible Dendra-2 reporter, that recently activated CD4 T cells enter downstream LNs via afferent lymphatics at high frequencies. Intra-lymphatic immune cell transfer and live imaging data further show that activated T cells come to an instantaneous arrest mediated passively by the mechanical 3D-sieve barrier of the LN subcapsular sinus (SCS). Arrested T cells subsequently migrate randomly on the sinus floor independent of both chemokines and integrins. However, chemokine receptors are imperative for guiding cells out of the SCS, and for their subsequent directional translocation towards the T cell zone. By contrast, integrins are dispensable for LN homing, yet still contribute by increasing the dwell time within the SCS and by potentially enhancing T cell sensing of chemokine gradients. Together, these findings provide fundamental insights into mechanisms that control homing of lymph-derived immune cells.


Subject(s)
CD4-Positive T-Lymphocytes/physiology , Cell Movement/immunology , Chemokines/metabolism , Integrins/metabolism , Lymph Nodes/physiology , Animals , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , Endothelium, Lymphatic/physiology , Integrins/genetics , Lymph/cytology , Lymph Nodes/cytology , Lymphocyte Activation , Mice , Receptors, Chemokine/genetics , Receptors, Chemokine/metabolism , Receptors, Lymphocyte Homing/metabolism
3.
J Leukoc Biol ; 107(6): 1155-1166, 2020 06.
Article in English | MEDLINE | ID: mdl-31841228

ABSTRACT

The majority of genetically modified C57BL/6 mice contain congenic passenger DNA around the targeted gene locus as they were generated from 129-derived embryonic stem cells (ESCs) with subsequent backcrossing to the C57BL/6 genetic background. When studying the role of atypical chemokine receptor 4 (ACKR4) in the immune system, we realized that the two available Ackr4-deficient mouse strains (Ackr4-/- and Ackr4GFP/GFP ) show profoundly different phenotypes: Compared to wild-type and Ackr4GFP/GFP mice, Ackr4-/- mice show a strong accumulation of plasma blasts in mesenteric lymph node and spleen as well as increased B cell proliferation after in vitro activation. This phenotype was maintained after further backcrossing to C57BL/6 mice and was even present in heterozygous Ackr4+/- animals, suggesting that a gene variant on the targeted chromosome might cause this phenotype. Exome sequencing revealed that a region of approximately 20 Mbp around the Ackr4 locus on chromosome 9 still originates from the 129 background based on high variant density observed. In activated Ackr4-/- and Ackr4GFP/GFP B cells, transcripts of genes around the Ackr4 locus were equally deregulated compared to C57BL/6 B cells, whereas increased expression of IL-6 was selectively observed in B cells of Ackr4-/- mice. Because the gene encoding for IL-6 is placed on chromosome 5 these findings suggest that passenger DNA around the Ackr4 locus has an indirect effect on B cell activation and IL-6 production. Results of the present study should not only lead to the reinterpretation of data from earlier studies using Ackr4-/- mice but should remind the scientific community about the limitations of mouse models using mice created by gene-targeting of nonsyngeneic ESCs.


Subject(s)
B-Lymphocytes/immunology , Chromosomes, Mammalian/immunology , Interleukin-6/genetics , Lymph Nodes/immunology , Lymphocyte Activation , Receptors, CCR/genetics , Animals , B-Lymphocytes/cytology , Cell Proliferation , Crosses, Genetic , Embryonic Stem Cells/cytology , Embryonic Stem Cells/immunology , Female , Genes, Reporter , Genetic Loci , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Heterozygote , Homozygote , Interleukin-6/immunology , Lymph Nodes/cytology , Male , Mesentery/cytology , Mesentery/immunology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Phenotype , Receptors, CCR/deficiency , Receptors, CCR/immunology , Spleen/cytology , Spleen/immunology , Exome Sequencing
4.
Swiss Med Wkly ; 149: w20102, 2019 Jun 03.
Article in English | MEDLINE | ID: mdl-31185128

ABSTRACT

Switzerland is aiming to eliminate measles, in line with the objectives of the World Health Organization (WHO). Physicians, laboratories and public health authorities have made great efforts to reach this goal. A continually increasing measles vaccination coverage and other preventive measures have made an impact: no major measles outbreak has been recorded since 2011. In order to evaluate progress towards elimination, measles epidemiology of a previous epidemic period (2007–2011) was compared with the current post-epidemic period (2012–July 2018) by analysis of data from the mandatory notification system. A decrease of 94% in the average annual incidence rate occurred between the two periods (from 133 to 9 cases per million inhabitants). This was accompanied by significant changes in the epidemiology that are expected and characteristic of countries with limited circulation of the measles virus. After analysing the performance of the Swiss surveillance system and the data provided, the WHO concluded that endemic measles transmission was interrupted in Switzerland in 2016 and 2017.


Subject(s)
Disease Eradication/trends , Epidemics/statistics & numerical data , Measles/epidemiology , Population Surveillance , Vaccination/statistics & numerical data , Adolescent , Adult , Child , Child, Preschool , Disease Notification , Disease Outbreaks/prevention & control , Female , Humans , Incidence , Infant , Male , Measles/prevention & control , Measles Vaccine/therapeutic use , Switzerland/epidemiology , Young Adult
5.
Immunol Rev ; 289(1): 62-83, 2019 05.
Article in English | MEDLINE | ID: mdl-30977201

ABSTRACT

Secondary lymphoid organs like lymph nodes (LNs) are the main inductive sites for adaptive immune responses. Lymphocytes are constantly entering LNs, scanning the environment for their cognate antigen and get replenished by incoming cells after a certain period of time. As only a minor percentage of lymphocytes recognizes cognate antigen, this mechanism of permanent recirculation ensures fast and effective immune responses when necessary. Thus, homing, positioning, and activation as well as egress require precise regulation within LNs. In this review we discuss the mediators, including chemokines, cytokines, growth factors, and others that are involved in the formation of the LN anlage and subsequent functional organization of LNs. We highlight very recent findings in the fields of LN development, steady-state migration in LNs, and the intranodal processes during an adaptive immune response.


Subject(s)
Chemokines/metabolism , Lymph Nodes/physiology , Lymphocytes/immunology , Adaptive Immunity , Animals , Cell Movement , Cytokines/metabolism , Humans , Lymphocyte Activation , Organogenesis
6.
Neurobiol Dis ; 102: 60-69, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28235673

ABSTRACT

Laquinimod is currently being tested as a therapeutic drug in multiple sclerosis. However, its exact mechanism of action is still under investigation. Tracking of fluorescently-tagged encephalitogenic T cells during experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis, revealed that laquinimod significantly reduces the invasion of pathogenic effector T cells into the CNS tissue. T-cell activation, differentiation and amplification within secondary lymphoid organs after immunization with myelin antigen, their migratory capacity and re-activation within the nervous tissue were either only mildly affected or remained unchanged. Instead, laquinimod directly impacted the functionality of the CNS vasculature. The expression of tight junction proteins p120 and ZO-1 in human brain endothelial cells was up-regulated upon laquinimod treatment, resulting in a significant increase in the transendothelial electrical resistance of confluent monolayers of brain endothelial cells. Similarly, expression of the adhesion molecule activated leukocyte cell adhesion molecule (ALCAM) and inflammatory chemokines CCL2 and IP-10 was suppressed, leading to a significant reduction in the migration of memory TH1 and TH17 lymphocytes across the blood brain barrier (BBB). Our data indicate that laquinimod exerts its therapeutic effects by tightening the BBB and limiting parenchymal invasion of effector T cells, thereby reducing CNS damage.


Subject(s)
Blood-Brain Barrier/drug effects , Blood-Brain Barrier/metabolism , Neuroprotective Agents/pharmacology , Quinolones/pharmacology , Adult , Animals , Capillary Permeability/drug effects , Capillary Permeability/physiology , Cells, Cultured , Encephalomyelitis, Autoimmune, Experimental/drug therapy , Encephalomyelitis, Autoimmune, Experimental/metabolism , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Female , Humans , Lymphocytes/drug effects , Lymphocytes/metabolism , Male , Mice, Inbred C57BL , Mice, Transgenic , Multiple Sclerosis, Relapsing-Remitting/drug therapy , Multiple Sclerosis, Relapsing-Remitting/metabolism , Rats, Inbred Lew , T-Lymphocytes/drug effects , T-Lymphocytes/metabolism , Young Adult
7.
Ther Umsch ; 73(5): 247-52, 2016.
Article in German | MEDLINE | ID: mdl-27268447

ABSTRACT

Adults, pregnant women, premature babies and immunocompromised persons are at increased risk for varicella complications. Therefore the current Swiss vaccination recommendations against varicella include a general recommendation for 11 to 15 year old adolescents with a negative varicella history, as well as a specific recommendation for risk groups. The goal of both recommendations is to reduce varicella complications in persons most at risk. The vaccine is not universally recommended for all toddlers in Switzerland, while this is the case in some countries such as the United States. Pros and cons of different vaccination strategies, as well as possible short- and long-term effects on herpes zoster incidence are taken into account. In the United States, there was a marked decline in incidence and hospitalisations, but an increased herpes zoster incidence in the short term. Finally, public health aspects of herpes zoster, post-herpetic neuralgia and possible vaccination strategies are outlined.


Subject(s)
Chickenpox Vaccine/administration & dosage , Chickenpox/prevention & control , Herpes Zoster/prevention & control , Adolescent , Adult , Chickenpox/epidemiology , Chickenpox/immunology , Chickenpox Vaccine/immunology , Child , Child, Preschool , Cross-Sectional Studies , Female , Herpes Zoster/epidemiology , Herpes Zoster/immunology , Herpes Zoster Vaccine/administration & dosage , Herpes Zoster Vaccine/immunology , Hospitalization/statistics & numerical data , Humans , Immunization, Secondary , Infant , Infant, Newborn , Opportunistic Infections/epidemiology , Opportunistic Infections/immunology , Opportunistic Infections/prevention & control , Pregnancy , Risk Factors , Switzerland
8.
PLoS One ; 9(5): e97695, 2014.
Article in English | MEDLINE | ID: mdl-24842154

ABSTRACT

Reporter genes inserted into viral genomes enable the easy and rapid quantification of virus replication, which is instrumental to efficient in vitro screening of antiviral compounds or in vivo analysis of viral spread and pathogenesis. Based on a published design, we have generated several replication competent influenza A viruses carrying either fluorescent proteins or Gaussia luciferase. Reporter activity could be readily quantified in infected cultures, but the virus encoding Gaussia luciferase was more stable than viruses bearing fluorescent proteins and was therefore analyzed in detail. Quantification of Gaussia luciferase activity in the supernatants of infected culture allowed the convenient and highly sensitive detection of viral spread, and enzymatic activity correlated with the number of infectious particles released from infected cells. Furthermore, the Gaussia luciferase encoding virus allowed the sensitive quantification of the antiviral activity of the neuraminidase inhibitor (NAI) zanamivir and the host cell interferon-inducible transmembrane (IFITM) proteins 1-3, which are known to inhibit influenza virus entry. Finally, the virus was used to demonstrate that influenza A virus infection is sensitive to a modulator of endosomal cholesterol, in keeping with the concept that IFITMs inhibit viral entry by altering cholesterol levels in the endosomal membrane. In sum, we report the characterization of a novel influenza A reporter virus, which allows fast and sensitive detection of viral spread and its inhibition, and we show that influenza A virus entry is sensitive to alterations of endosomal cholesterol levels.


Subject(s)
Antiviral Agents/pharmacology , Copepoda/enzymology , Influenza A virus/metabolism , Luciferases , Proteins/pharmacology , Virus Replication/physiology , Animals , Antigens, Differentiation , Biological Assay/methods , Cloning, Molecular , Copepoda/genetics , Genes, Reporter/genetics , Genes, Reporter/physiology , Genetic Engineering/methods , Genetic Vectors , Influenza A virus/enzymology , Luciferases/metabolism , Virology/methods , Virus Replication/drug effects , Zanamivir
SELECTION OF CITATIONS
SEARCH DETAIL
...